breast cancer Archives | Be Korea-savvy
TRIO Enrols First Patient in Global Phase 3 Giredestrant Early Breast Cancer Trial

TRIO Enrols First Patient in Global Phase 3 Giredestrant Early Breast Cancer Trial

EDMONTON, Alberta, Aug. 31 (Korea Bizwire) — Translational Research in Oncology (TRIO), a global academic clinical research organization, announced today enrolment of first patient in the LidERA Breast Cancer (TRIO045) trial, a Phase 3 randomized, multi-center, open-label global clinical trial of adjuvant endocrine therapy, giredestrant (GDC-9545) sponsored by F. Hoffmann-LaRoche. Giredestrant is an oral selective [...]

TRIO Completes Enrolment for Phase 2 Giredestrant Early Breast Cancer Trial Ahead of Schedule

TRIO Completes Enrolment for Phase 2 Giredestrant Early Breast Cancer Trial Ahead of Schedule

EDMONTON, Alberta, July 6 (Korea Bizwire) — Translational Research in Oncology (TRIO), a global academic clinical research organization, announced today enrolment completion in coopERA Breast Cancer (WO42133/TRIO038), a Phase 2 randomized, multi-center, open-label clinical trial of giredestrant (GDC-9545) sponsored by F. Hoffmann-La Roche. This comes shortly after completion of the planned study interim analysis provided [...]

AI Offers Accurate Prediction of Chemotherapy Effectiveness Prior to Breast Cancer Surgery

AI Offers Accurate Prediction of Chemotherapy Effectiveness Prior to Breast Cancer Surgery

SEOUL, Dec. 7 (Korea Bizwire) — South Korean researchers have developed new technology that uses artificial intelligence (AI) to anticipate the effects of chemotherapy for breast cancer patients. The Korea Institute of Radiological Medical Sciences announced recently that an AI deep learning mechanism can be used to anticipate the effects of chemotherapy for breast cancer [...]

Areolar Incision Technique Brings New Hope to Breast Cancer Patients

Areolar Incision Technique Brings New Hope to Breast Cancer Patients

SEOUL, Dec. 2 (Korea Bizwire) — The scars left after breast cancer surgery are among the factors that greatly worsen quality of life for patients. Fortunately, however, the areolar incision technique is emerging as an alternative that leaves almost no scars. A recent study showed that the areolar incision technique has no significant differences in [...]

Samsung Bioepis’ Breast Cancer Biosimilar Hits U.S.

Samsung Bioepis’ Breast Cancer Biosimilar Hits U.S.

SEOUL, April 16 (Korea Bizwire) — South Korean biopharmaceutical firm Samsung Bioepis Co. said Thursday its breast cancer biosimilar Ontruzant is now available in the United States. Global health care company MSD has begun distributing the biosimilar that references Switzerland-based Roche Holding’s Herceptin, also known as Trastuzumab, in the world’s largest pharmaceutical market, Samsung Bioepis [...]

Preventive Surgery Increasingly Popular After Angelina Jolie’s Cancer Treatment Reveal

Preventive Surgery Increasingly Popular After Angelina Jolie’s Cancer Treatment Reveal

SEOUL, Apr. 3 (Korea Bizwire) — An increasing number of breast cancer patients, after discovering a tumor in one of their breasts, are resorting to preventative surgeries to remove both breasts or ovaries to prevent tumors from spreading. Preventive surgeries have been on the rise ever since Hollywood actress Angelina Jolie revealed that she received [...]

TRIO Awarded NATALEE Study, Largest Single Phase III Breast Cancer Clinical Trial in its History

TRIO Awarded NATALEE Study, Largest Single Phase III Breast Cancer Clinical Trial in its History

EDMONTON, Alberta, Jul. 9 (Korea Bizwire) — Translational Research In Oncology (TRIO) today announced a collaboration with Novartis on its upcoming phase III clinical trial of ribociclib with endocrine therapy in the adjuvant treatment of HR-positive, HER2-negative early breast cancer (EBC). The trial will be called NATALEE (New Adjuvant TriAl with LEE). “Ribociclib in combination [...]

Late Childbearing and C-sections Linked to Breast Cancer

Late Childbearing and C-sections Linked to Breast Cancer

SEOUL, March 31 (Korea Bizwire) – A recent study from the Korea University Guro Hospital revealed delayed childbearing and cesarean section delivery increases the risk of breast cancer by 280 percent. The researchers looked at the correlation between the incidence of breast cancer and late childbirth and c-section delivery, and found that mothers who gave birth [...]